Drug Manufacturing

Groupe PARIMA approaches drug manufacturing with disciplined GMP execution across all production stages.

Mixing Vessel for Drug Manufacturing

Reliable GMP Drug Manufacturing at Every Stage

A manufacturing site built for GMP control, flexibility, and dependable execution.

Groupe PARIMA provides flexible pharmaceutical manufacturing across the full product lifecycle, from clinical production to commercial supply.

Our GMP‑compliant manufacturing facility supports scale‑up, tech transfer, and commercial production under the same rigorous quality systems, regardless of product complexity or batch size.

High‑constraint manufacturing control

Complex drug products demand manufacturing approaches that extend beyond standard GMP execution. At Groupe PARIMA, we meet these requirements through a tightly integrated manufacturing environment where process control and quality oversight operate as a unified system to provide consistency across the full product lifecycle.

Hazardous materials control

Hazardous Materials Control

We handle hazardous materials through controlled processes, engineered containment, and trained teams, ensuring operator protection while maintaining product quality and process integrity.

Protection for sensitive products

Protection for Sensitive Products

Amber‑lit manufacturing environments and inert gas atmospheres support the controlled manufacture of light or oxygen-sensitive formulations.

safe scale-up for volatile formulaitons-

Safe Scale‑Up for Volatile Formulations

Dedicated Class I, Division 1 (1D1) rated explosion‑proof suites support alcohol‑based and other flammable formulations, enabling controlled scale‑up from small clinical batches to production volumes ranging from 5 to 1,600 kg.

Standardized batch overshight

Standardized Batch Oversight

Integrated quality systems ensure the same level of GMP control and oversight is applied across all manufacturing activities, supporting consistent execution regardless of product complexity or production scale.

Manufacturing designed for Control and Scale

Pharmaceutical vessels are selected and configured to meet formulation and process requirements, enabling consistent mixing, blending, and homogenization. Our equipment provides control over critical process parameters for formulations with narrow operating windows or complex rheological behavior.

01
Integrated Temperature Control

Integrated Temperature Control

Fully jacketed manufacturing tanks with integrated temperature control systems support diverse product temperature profiles.

02
uniform mixing and blending

Uniform Mixing and Blending

Sweep and counter‑sweep mixing systems promote formulation uniformity and consistency across a wide range of viscosities.

03
Homogeineizers

Controlled Emulsification Process

High‑shear homogenizers enable controlled emulsification and effective particle size reduction.

04
Versatile Secondary Processing

Versatile Secondary Processing

A range of secondary processing equipment, including rotosolvers, top-mounted homogenizers, and colloid mills, supports diverse formulation requirements.

05
Enhanced Vacuum Capability_

Enhanced Vacuum Capability

Our equipment permits controlled vacuum conditions during manufacturing to eliminate air entrapment and maintain the homogeneity of finished products.

We embed quality into every manufacturing decision, guiding how processes are designed, executed, and controlled under regulatory compliance and GMP guidelines.

Manufacturing Capability Across Scales

Broad manufacturing capacities reflect our ability to support products from early clinical batches through sustained commercial supply.

5 to 2,500 kg

Batch Sizes

Creams, gels, and ointments across development, scale‑up, and commercial production.

2 to 4,000 kg

Batch Sizes

Liquids and suspensions produced at multiple scales for clinical and commercial needs.

30M Units

Annually Capacity

High‑capacity packaging operations supporting sustained commercial demand.

Resources

Explore resources focused on drug manufacturing that impact process design, scale‑up, and commercial execution.

White papers
2026/07/06
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
White papers
2026/07/03
How Early API Characterization Can Reduce Formulation and Scale-up Risks
White papers
2026/07/06
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
White papers
2026/07/03
How Early API Characterization Can Reduce Formulation and Scale-up Risks

Contact us

Discuss Your Drug Manufacturing Requirements

Contact our team to discuss how our GMP manufacturing capabilities can support your product from development through commercial production.